These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 18988124)

  • 1. Pharma Law Europe - Eighth Annual Conference.
    Indraccolo AD; Chapman C
    IDrugs; 2008 Nov; 11(11):807-10. PubMed ID: 18988124
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharma patents in Europe: where are we going?
    Becker K
    Future Med Chem; 2009 May; 1(2):227-30. PubMed ID: 21425963
    [No Abstract]   [Full Text] [Related]  

  • 3. Anxious wait for patients and big pharma.
    Kirby T
    Lancet Neurol; 2015 Mar; 14(3):246-7. PubMed ID: 25728435
    [No Abstract]   [Full Text] [Related]  

  • 4. European Commission's proposals on trade secrets.
    McKee M; Labonté R
    BMJ; 2015 Mar; 350():h1369. PubMed ID: 25762539
    [No Abstract]   [Full Text] [Related]  

  • 5. Indian pharma enters the global arena.
    Singh S
    Cell; 2007 Mar; 128(5):811-4. PubMed ID: 17350563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Harmonization of biotechnological regulations in the European Community.
    Sauer F
    Bioprocess Technol; 1991; 13():455-68. PubMed ID: 1367146
    [No Abstract]   [Full Text] [Related]  

  • 7. Protecting profits.
    Neroth P
    Lancet; 2004 Oct 2-8; 364(9441):1207-8. PubMed ID: 15470807
    [No Abstract]   [Full Text] [Related]  

  • 8. Biotech patents-business as usual?
    Lawrence S
    Nat Biotechnol; 2008 Dec; 26(12):1326. PubMed ID: 19060861
    [No Abstract]   [Full Text] [Related]  

  • 9. Generics, Supergenerics and Patent Strategies--SMi's 13th Annual Meeting.
    Edwards C
    IDrugs; 2010 Jul; 13(7):433-6. PubMed ID: 20582864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Looking inward: regional parallel trade as a means of bringing affordable drugs to Africa.
    Buckely M
    Seton Hall Law Rev; 2011; 41(2):625-69. PubMed ID: 21739760
    [No Abstract]   [Full Text] [Related]  

  • 11. A license to print money?
    Nat Biotechnol; 2006 Jun; 24(6):593. PubMed ID: 16763570
    [No Abstract]   [Full Text] [Related]  

  • 12. Alnylam dealt blow.
    Mullard A
    Nat Biotechnol; 2009 Mar; 27(3):213. PubMed ID: 19270653
    [No Abstract]   [Full Text] [Related]  

  • 13. European Commission takes on Big Pharma.
    den Exter A
    Lancet; 2009 Aug; 374(9690):599-600. PubMed ID: 19699998
    [No Abstract]   [Full Text] [Related]  

  • 14. [OBLIGATORY LICENSE ON PATENTS AND THE PUBLIC INTEREST].
    BANCI F
    Boll Chim Farm; 1964 Dec; 103():843-6. PubMed ID: 14261692
    [No Abstract]   [Full Text] [Related]  

  • 15. European Union joins fight over drug patents.
    Watson R
    BMJ; 2001 Jul; 323(7303):12. PubMed ID: 11440933
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmaceutical Portfolio & Product Life Cycle Management--SMi's fourth annual conference. 29-30 June 2009, London, UK.
    Beecher N
    IDrugs; 2009 Sep; 12(9):558-60. PubMed ID: 19697274
    [No Abstract]   [Full Text] [Related]  

  • 17. Taking TRIPS to India--Novartis, patent law, and access to medicines.
    Mueller JM
    N Engl J Med; 2007 Feb; 356(6):541-3. PubMed ID: 17287473
    [No Abstract]   [Full Text] [Related]  

  • 18. European Commission's inquiry into the pharmaceuticals sector.
    Ager B
    Lancet; 2009 Nov; 374(9704):1819; author reply 1819-20. PubMed ID: 19944861
    [No Abstract]   [Full Text] [Related]  

  • 19. Product patents.
    Griffin J
    Lancet; 1991 Dec; 338(8781):1528. PubMed ID: 1683951
    [No Abstract]   [Full Text] [Related]  

  • 20. Intellectual property law in Israel, and US and European objections: Market exclusivity vs. data exclusivity.
    Morag-Sela T; Cohn I; Kowalski TJ; Jarecki-Black J; Clyde-Watson Z
    Nat Biotechnol; 2004 Dec; 22(12):1591-2. PubMed ID: 15583670
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.